STOCK TITAN

Eyenovia, Inc. 8-K Filings

EYEN NASDAQ

Every 8-K that Eyenovia, Inc. (EYEN) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow EYEN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EYEN filings page.

Rhea-AI Summary

Eyenovia announced a significant strategic shift through a $50 million private placement and entry into cryptocurrency markets. The company sold 5,128,205 shares of Series A Non-Voting Preferred Stock and warrants to institutional investors, with each preferred share convertible into three common shares.

Key developments include:

  • Appointment of Hyunsu Jung (age 29) as Chief Investment Officer and Director, with a $250,000 salary and equity incentives
  • Plans to build reserves of HYPE tokens and implement a staking program while continuing development of Gen-2 Optejet Device
  • Board restructuring with resignations of Sean Ianchulev, Charles Mather IV, and Ram Palanki
  • Amendment to loan agreement with Avenue Capital, extending maturity to 2028 and reducing interest from 12% to 8%

The private placement includes warrants exercisable at $3.25 per share after six months, with Chardan Capital Markets acting as placement agent. The company's pro forma shares outstanding would increase to 54,027,429 upon full conversion of preferred shares and warrant exercise.